Triple-negative breast cancer (TNBC) accounts for 20%-25% of breast cancer cases. Around 10%-15% of patients with breast cancer present with upfront metastasis. Lymph node, bone, and liver are common sites of metastasis in hormone-positive breast cancer while brain, lungs, and liver in TNBC. Although visceral metastasis is common in TNBC, metastasis to stomach is unusual. Morphological similarity of primary gastric carcinoma and lobular invasive breast carcinoma often leads to misdiagnosis. Meticulous review of histopathology and immunohistochemistry is essential for diagnosis. We present a case of carcinoma breast with unusual gastric nodular metastasis detected on 18 F-fluorodeoxyglucose positron emission tomography-computed tomography.
A 47-year-old woman presented with complaints of a lump in her left breast for 8 months and dyspepsia for 1month. Trucut biopsy from the left breast lump showed invasive ductal carcinoma (IDC). Immunohistochemistry(IHC) showed negative estrogen receptor(ER, Allred score 0/8), progesterone receptor (PR, Allred score 0/8), and Her2neu staining, but immunopositive for GATA-binding protein 3(GATA 3). 18 Triple-negative breast cancer (TNBC) accounts for 20%-25% of breast cancer cases. Lymph node, bone, and liver are common sites of metastasis in hormone receptor-positive breast cancer while lung, brain, and liver are common in TNBC. [1] Visceral metastasis is common in TNBC; however, metastasis to stomach is uncommon. Further, there is considerable difference in pattern of metastatic spread between invasive lobular carcinoma (ILC) and IDC, with common sites of metastases reported with IDC being bone, lungs, and liver. On the contrary, ILC has greater propensity for metastasis to GI tract, peritoneum, and pelvic organs. [2] [3] [4] Isolated gastric metastases are rare; they usually have multiple other sites of metastasis. A study done by Xu et al. has 
shown that breast
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For reprints contact: reprints@medknow.com cancer patients with gastric metastasis have simultaneous bone, liver, and lungs metastases in 50%, 20.4%, and 12.2%, respectively. [5] Linitis plastica (diffuse infiltration of muscle layer) is the most common subtype associated with gastric metastasis, while submucosal nodular variant is relatively uncommon. Morphological similarity of signet ring gastric carcinoma and invasive lobular breast carcinoma also complicates diagnosis and needs further immunostaining to avoid misdiagnosis. Primary gastric cancer can also show positivity for ER and ER in 32% and 12%, respectively, hence that is inadequate for confirming a definite metastasis from breast cancer. [6] GATA 3 is part of GATA family of zinc-finger binding transcription factors which are involved in the differentiation of many cell types. [7] It is expressed in many tissues at low level which is usually not detectable by IHC, and it has been shown as a specific IHC marker for breast and urothelial carcinomas. [8] Regarding breast cancer, it is of most significance in TNBC, where proving origin from the breast is difficult by IHC (ER−/PR−/Her2−). Positive cytoplasmic staining for GCDFP-15 has also been found to be a sensitive (55%-76%) and specific (95%-100%) marker to establish mammary origin and correctly identify lesion to be metastatic from breast primary. [9] Our patient has completed three cycles of chemotherapy (paclitaxel 175 mg/m 2 every 3 weeks) until now, and she is under regular follow-up.
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